159938 GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS
Trading 05-13 13:54:42
0.64
-0.01
-0.93%
High
0.65
Low
0.64
Vol
29.82M
Open
0.65
D1 Closing
0.65
Amplitude
1.40%
Mkt Cap
0.00
Tradable Cap
0.00
Total Shares
0.00
T/O
19.10M
T/O Rate
--
Tradable Shares
0.00
P/B
--
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
Loading ...
News
New Post(s)
Profile
China Securities' Mid-2026 Pharmaceutical Investment Strategy: Differentiation and Global Value Realization
Stock News · 11:48
China Securities' Mid-2026 Pharmaceutical Investment Strategy: Differentiation and Global Value Realization
Wanlian Securities: Q1 2026 Public Fund Healthcare Holdings Concentrate on Innovation Chain, Suggest Focus on Biotech and Major Pharma
Stock News · 10:43
Wanlian Securities: Q1 2026 Public Fund Healthcare Holdings Concentrate on Innovation Chain, Suggest Focus on Biotech and Major Pharma
Pharmaceutical Retail Sector Shows Clear Turnarounds in Performance and Valuation, Awaiting Multiple Catalysts
Stock News · 07:55
Pharmaceutical Retail Sector Shows Clear Turnarounds in Performance and Valuation, Awaiting Multiple Catalysts
Fruit and Vegetable Giant's $700 Million Foray into Pharmaceuticals: Can New Controlling Shareholder Turn the Tide?
Deep News · 05-12 17:24
Fruit and Vegetable Giant's $700 Million Foray into Pharmaceuticals: Can New Controlling Shareholder Turn the Tide?
GTHT: Favorable Industry Trends Persist in 1Q26, Innovative Drugs Remain Key Driver of Pharmaceutical Sector Momentum
Stock News · 05-12 16:10
GTHT: Favorable Industry Trends Persist in 1Q26, Innovative Drugs Remain Key Driver of Pharmaceutical Sector Momentum
Multiple Tailwinds Converge, Hong Kong Biotech Sector Enters Favorable Investment Window; FG's HK Connect Healthcare Fund Launches Today
Deep News · 05-11 15:51
Multiple Tailwinds Converge, Hong Kong Biotech Sector Enters Favorable Investment Window; FG's HK Connect Healthcare Fund Launches Today
Commercial Bribery or Risk Compensation? Insurers Grapple with Pharmaceutical Discounts
Deep News · 05-11 15:37
Commercial Bribery or Risk Compensation? Insurers Grapple with Pharmaceutical Discounts
Industrial Securities Forecasts Pharmaceutical Sector Stabilization in 2025, Growth Continues into Q1 2026
Stock News · 05-11 15:03
Industrial Securities Forecasts Pharmaceutical Sector Stabilization in 2025, Growth Continues into Q1 2026
Era of Universal Growth Ends for Healthcare Sector, Redefining Survival Thresholds
Deep News · 05-09
Era of Universal Growth Ends for Healthcare Sector, Redefining Survival Thresholds
Major A-Share Indices Open Lower; AI Applications, Pharmaceuticals, and Baijiu Lead Gains
Stock News · 05-08
Major A-Share Indices Open Lower; AI Applications, Pharmaceuticals, and Baijiu Lead Gains
BIOSTAR PHARM-B Proposes Adoption of Share Option Scheme
Stock News · 05-07
BIOSTAR PHARM-B Proposes Adoption of Share Option Scheme
Beijing Hotgen Biotech's Subsidiary Secures Beijing's "Specialized, Refined, Unique, and Innovative" SME Certification
Stock News · 05-07
Beijing Hotgen Biotech's Subsidiary Secures Beijing's "Specialized, Refined, Unique, and Innovative" SME Certification
Pharmaceutical Firm Aibang Medicine Files for Hong Kong IPO with Commercial Product and Global Pipeline
Stock News · 05-06
Pharmaceutical Firm Aibang Medicine Files for Hong Kong IPO with Commercial Product and Global Pipeline
Measures to Strengthen Tibetan Medicine Industry
Deep News · 05-06
Measures to Strengthen Tibetan Medicine Industry
China's Pharmaceutical Brands Reach $12.09 Billion in Value on Brand Finance 2026 Global Ranking
Deep News · 04-30
China's Pharmaceutical Brands Reach $12.09 Billion in Value on Brand Finance 2026 Global Ranking
Prospective IPO Analysis: Huilun Pharma's Distant Pipeline Fails to Address Immediate Woes; When Will It Emerge from Transition Pains?
Stock News · 04-30
Prospective IPO Analysis: Huilun Pharma's Distant Pipeline Fails to Address Immediate Woes; When Will It Emerge from Transition Pains?
ZhongOu Fund Appoints Tech Specialist Dai Yunfeng to Succeed Ge Lan as Manager of Mingrui New Starting Fund
Deep News · 04-29
ZhongOu Fund Appoints Tech Specialist Dai Yunfeng to Succeed Ge Lan as Manager of Mingrui New Starting Fund
BIOSTAR PHARM-B Proposes Appointment of Zhu Xiaodong as Independent Non-Executive Director
Stock News · 04-28
BIOSTAR PHARM-B Proposes Appointment of Zhu Xiaodong as Independent Non-Executive Director
Pharmaceutical "Pickaxe Sellers" Surge Nearly 15%! Revival in Innovative Drug Investment Ignites Orders
Deep News · 04-28
Pharmaceutical "Pickaxe Sellers" Surge Nearly 15%! Revival in Innovative Drug Investment Ignites Orders
GENFLEET-B (02595) Clarifies No Connection to Rev Med's Legal Dispute
Stock News · 04-28
GENFLEET-B (02595) Clarifies No Connection to Rev Med's Legal Dispute
Load more
Introduction
Company Name.
--
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--
{"stockData":{"symbol":"159938","market":"SZ","secType":"STK","nameCN":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS","latestPrice":0.639,"timestamp":1778651682000,"preClose":0.645,"halted":0,"volume":29815500,"delay":0,"changeRate":-0.0093,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-0.006,"latestTime":"05-13 13:54:42","open":0.645,"high":0.647,"low":0.638,"amount":19097500,"amplitude":0.014,"askPrice":0.64,"askSize":67975,"bidPrice":0.639,"bidSize":14131,"shortable":0,"etf":1,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1778655600000},"marketStatusCode":2,"adr":0,"adjPreClose":0.645,"symbolType":"fund","openAndCloseTimeList":[[1778635800000,1778643000000],[1778648400000,1778655600000]],"highLimit":0.71,"lowLimit":0.581,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":0.162696,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/159938","defaultTab":"news","newsList":[{"id":"1102874861","title":"China Securities' Mid-2026 Pharmaceutical Investment Strategy: Differentiation and Global Value Realization","url":"https://stock-news.laohu8.com/highlight/detail?id=1102874861","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102874861?lang=en_us&edition=fundamental","pubTime":"2026-05-13 11:48","pubTimestamp":1778644117,"startTime":"0","endTime":"0","summary":"According to a research report from China Securities Co., Ltd., the pharmaceutical industry is expected to bottom out and recover in the first half of 2026. Multiple innovative drug companies are...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159938","BK1515","BK0276","09939","601066","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166402898","title":"Wanlian Securities: Q1 2026 Public Fund Healthcare Holdings Concentrate on Innovation Chain, Suggest Focus on Biotech and Major Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1166402898","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166402898?lang=en_us&edition=fundamental","pubTime":"2026-05-13 10:43","pubTimestamp":1778640186,"startTime":"0","endTime":"0","summary":"Wanlian Securities released a research report stating that as of Q1 2026, the structure of public fund holdings in the healthcare sector continues to concentrate towards the innovation chain,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1515","BK4588","HBImain","BK4581","159837","161027","BK1574","159938","XBI","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175800418","title":"Pharmaceutical Retail Sector Shows Clear Turnarounds in Performance and Valuation, Awaiting Multiple Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1175800418","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175800418?lang=en_us&edition=fundamental","pubTime":"2026-05-13 07:55","pubTimestamp":1778630108,"startTime":"0","endTime":"0","summary":"CITIC Securities points out that the traditional Chinese medicine (TCM) sector is expected to see short-term base pressure ease. Companies are actively promoting channel reforms and improving quality...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK0276","BK1515","BK1161","159938","601066","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132162078","title":"Fruit and Vegetable Giant's $700 Million Foray into Pharmaceuticals: Can New Controlling Shareholder Turn the Tide?","url":"https://stock-news.laohu8.com/highlight/detail?id=1132162078","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132162078?lang=en_us&edition=fundamental","pubTime":"2026-05-12 17:24","pubTimestamp":1778577897,"startTime":"0","endTime":"0","summary":"The A-share market has maintained a high level of activity in mergers and acquisitions since 2026. According to Wind data, over 130 companies disclosed progress related to M&A activities in the first...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","159938","BK1161","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126398696","title":"GTHT: Favorable Industry Trends Persist in 1Q26, Innovative Drugs Remain Key Driver of Pharmaceutical Sector Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1126398696","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126398696?lang=en_us&edition=fundamental","pubTime":"2026-05-12 16:10","pubTimestamp":1778573444,"startTime":"0","endTime":"0","summary":"According to a research report from Guotai Haitong (GTHT), the overall revenue of large pharmaceutical companies, small and medium-sized pharmaceutical enterprises, and commercialized biotech firms...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1147","BK1161","601211","BK1564","06978","BK1574","159938","BK0012","02611","BK0183","09939","BK0201","BK0276","BK1515","BK0188","BK0028","BK0184"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155800988","title":"Multiple Tailwinds Converge, Hong Kong Biotech Sector Enters Favorable Investment Window; FG's HK Connect Healthcare Fund Launches Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1155800988","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155800988?lang=en_us&edition=fundamental","pubTime":"2026-05-11 15:51","pubTimestamp":1778485882,"startTime":"0","endTime":"0","summary":"Since May, the Hong Kong-listed innovative drug sector has continued to gain momentum, with clear signs of capital returning. Wind data shows that several Hong Kong-listed innovative drug ETFs have...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","VXUS","09939","BK4588","159992","BK1161","BK1515","BK4585","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117283184","title":"Commercial Bribery or Risk Compensation? Insurers Grapple with Pharmaceutical Discounts","url":"https://stock-news.laohu8.com/highlight/detail?id=1117283184","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117283184?lang=en_us&edition=fundamental","pubTime":"2026-05-11 15:37","pubTimestamp":1778485022,"startTime":"0","endTime":"0","summary":"Since late April 2026, Wu Hao has frequently sought feedback from his company's risk control and compliance department regarding a new commercial health insurance product. As the business head of the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1515","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198479216","title":"Industrial Securities Forecasts Pharmaceutical Sector Stabilization in 2025, Growth Continues into Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1198479216","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198479216?lang=en_us&edition=fundamental","pubTime":"2026-05-11 15:03","pubTimestamp":1778482983,"startTime":"0","endTime":"0","summary":"Industrial Securities released a research report stating that \"innovation + globalization\" will remain the core theme for the pharmaceutical and biotechnology sector in 2026. The focus should be on...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1574","BK0012","BK0188","BK1515","BK0183","BK0276","601377","159938","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151463424","title":"Era of Universal Growth Ends for Healthcare Sector, Redefining Survival Thresholds","url":"https://stock-news.laohu8.com/highlight/detail?id=1151463424","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151463424?lang=en_us&edition=fundamental","pubTime":"2026-05-09 08:32","pubTimestamp":1778286727,"startTime":"0","endTime":"0","summary":"The earnings season has concluded, and the anticipated broad-based recovery in the healthcare sector did not materialize. What truly transpired is a fundamental shift in the industry's valuation...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","159938","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168891496","title":"Major A-Share Indices Open Lower; AI Applications, Pharmaceuticals, and Baijiu Lead Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1168891496","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168891496?lang=en_us&edition=fundamental","pubTime":"2026-05-08 09:41","pubTimestamp":1778204513,"startTime":"0","endTime":"0","summary":"On May 8, the three major A-share indices opened collectively lower. The Shanghai Composite Index fell by 0.39%, while the ChiNext Index dropped by 1.07%. In terms of sector performance, AI...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIQ","09939","BK1161","BK4585","159982","BK1574","BK4588","159938","399300","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188710206","title":"BIOSTAR PHARM-B Proposes Adoption of Share Option Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1188710206","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188710206?lang=en_us&edition=fundamental","pubTime":"2026-05-07 23:08","pubTimestamp":1778166492,"startTime":"0","endTime":"0","summary":"BIOSTAR PHARM-B (02563) announced that on May 6, 2026, the board of directors resolved to adopt a share option plan pursuant to Chapter 17 of the Listing Rules. The plan is intended to provide...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02563","BK1574","BK1161","159938","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160493900","title":"Beijing Hotgen Biotech's Subsidiary Secures Beijing's \"Specialized, Refined, Unique, and Innovative\" SME Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=1160493900","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160493900?lang=en_us&edition=fundamental","pubTime":"2026-05-07 21:20","pubTimestamp":1778160019,"startTime":"0","endTime":"0","summary":"Beijing Hotgen Biotech Co., Ltd. (688068.SH) has announced that its controlling subsidiary, Beijing Shunjing Biopharmaceutical Technology Co., Ltd. (Shunjing Pharma), recently received a certificate...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","688068","BK1515","159938","09939","BK0239","399267","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113210935","title":"Pharmaceutical Firm Aibang Medicine Files for Hong Kong IPO with Commercial Product and Global Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1113210935","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113210935?lang=en_us&edition=fundamental","pubTime":"2026-05-06 10:31","pubTimestamp":1778034700,"startTime":"0","endTime":"0","summary":"Aibang Medicine has submitted an application to list on the Hong Kong Stock Exchange, marking a strategic shift from a research-focused entity to one driven by both research and commercial...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","VXUS","BK1574","BK1515","BK4588","BK4585","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135968625","title":"Measures to Strengthen Tibetan Medicine Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=1135968625","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135968625?lang=en_us&edition=fundamental","pubTime":"2026-05-06 01:50","pubTimestamp":1778003434,"startTime":"0","endTime":"0","summary":"As of May 1, the Tibetan Hospital in Zekog County, Huangnan Tibetan Autonomous Prefecture, has developed 214 types of self-made Tibetan medicines, with 104 included in the national medical insurance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159938","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133828691","title":"China's Pharmaceutical Brands Reach $12.09 Billion in Value on Brand Finance 2026 Global Ranking","url":"https://stock-news.laohu8.com/highlight/detail?id=1133828691","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133828691?lang=en_us&edition=fundamental","pubTime":"2026-04-30 16:00","pubTimestamp":1777536038,"startTime":"0","endTime":"0","summary":"On April 30, 2026, the Brand Finance 2026 Global Pharmaceutical Brand Value Ranking was released. The report indicates that ten Chinese pharmaceutical companies have entered the global top 50, with a...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1515","BK1161","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140579206","title":"Prospective IPO Analysis: Huilun Pharma's Distant Pipeline Fails to Address Immediate Woes; When Will It Emerge from Transition Pains?","url":"https://stock-news.laohu8.com/highlight/detail?id=1140579206","media":"Stock News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140579206?lang=en_us&edition=fundamental","pubTime":"2026-04-30 10:29","pubTimestamp":1777516158,"startTime":"0","endTime":"0","summary":"Shanghai Huilun Pharmaceutical Co., Ltd. has submitted a listing application to the main board of the Hong Kong Stock Exchange, with CITIC Securities acting as the sole sponsor. Prior to this, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09939","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181164348","title":"ZhongOu Fund Appoints Tech Specialist Dai Yunfeng to Succeed Ge Lan as Manager of Mingrui New Starting Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=1181164348","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181164348?lang=en_us&edition=fundamental","pubTime":"2026-04-29 09:20","pubTimestamp":1777425641,"startTime":"0","endTime":"0","summary":"On April 29, ZhongOu Fund announced that Dai Yunfeng will replace Ge Lan as the fund manager of ZhongOu Mingrui New Starting Fund. The latest quarterly report shows the fund's top ten holdings are...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","09939","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177239677","title":"BIOSTAR PHARM-B Proposes Appointment of Zhu Xiaodong as Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1177239677","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177239677?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:54","pubTimestamp":1777384464,"startTime":"0","endTime":"0","summary":"BIOSTAR PHARM-B (02563) has announced that Dr. Meng Songdong has tendered his resignation from his positions as an independent non-executive director, chairman of the remuneration and assessment...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09939","159938","02563","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195934397","title":"Pharmaceutical \"Pickaxe Sellers\" Surge Nearly 15%! Revival in Innovative Drug Investment Ignites Orders","url":"https://stock-news.laohu8.com/highlight/detail?id=1195934397","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195934397?lang=en_us&edition=fundamental","pubTime":"2026-04-28 13:51","pubTimestamp":1777355491,"startTime":"0","endTime":"0","summary":"WuXi AppTec's order backlog has reached a record high. Following the release of its first-quarter results, WuXi AppTec, a leading \"pickaxe seller\" in the pharmaceutical industry, saw its stock price...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1161","159992","09939","BK1574","BK1515","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133388661","title":"GENFLEET-B (02595) Clarifies No Connection to Rev Med's Legal Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=1133388661","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133388661?lang=en_us&edition=fundamental","pubTime":"2026-04-28 12:40","pubTimestamp":1777351214,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has issued an announcement stating that the company recently noted several reports concerning a letter sent by Revolution Medicines Inc. (\"Rev Med\") to a third-party company...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161","09939","159938","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"stockEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":-0.0107},{"period":"3month","weight":-0.033},{"period":"6month","weight":-0.0877},{"period":"1year","weight":0.0591},{"period":"ytd","weight":-0.0062}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0573},{"period":"3month","weight":0.02},{"period":"6month","weight":0.0459},{"period":"1year","weight":0.2509},{"period":"ytd","weight":0.0619}],"serverTime":1778651684596,"compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS,159938,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票老虎,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票老虎国际,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS行情,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票行情,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股价,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股市,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票价格,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票交易,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票购买,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}